CHRS - Coherus BioSciences announces departure of finance chief McDavid Stilwell
2023-12-07 18:04:47 ET
More on Coherus BioSciences
- Coherus BioSciences Is A Buy On The Dip After Toripalimib Approval
- Coherus: The Surface Acquisition Is A Distraction
- Coherus BioSciences, Inc. (CHRS) Q3 2023 Earnings Call Transcript
For further details see:
Coherus BioSciences announces departure of finance chief McDavid Stilwell